MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

MDT

95.99

+0.39%↑

VEEV

284.61

+0.57%↑

143.05

+0.81%↑

HQY

93.09

+2.08%↑

TLRY

1.56

+0.65%↑

Начало・Списък с акции・Geron Corp

Geron Corp

Затворен

СекторЗдравеопазване

1.26 5

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.2

Максимум

1.27

Ключови измерители
By Trading Economics
Приходи	3.5M -16M
Продажби	9.4M 49M
Марж на печалбата	-33.394
Служители	229
EBITDA	9.2M -7.6M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+175.59% upside

Дивиденти
By Dow Jones
Следващи печалби	6.11.2025 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	40M 810M
Предишно отваряне	-3.74
Предишно затваряне	1.26

Настроения в новините

By Acuity

47%

53%

153 / 371 Класиране в Healthcare

Geron Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

20.10.2025 г., 23:43 ч. UTC

Пазарно говорене

Nikkei May Rise on Hopes for Takaichi's Policy Steps -- Market Talk

20.10.2025 г., 23:43 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

20.10.2025 г., 23:36 ч. UTC

Пазарно говорене

Gold Edges Higher on Likely Dip-Buying Interest -- Market Talk

20.10.2025 г., 22:14 ч. UTC

Пазарно говорене

Zions Management Confident $50M Charge Was Isolated Event -- Market Talk

20.10.2025 г., 22:00 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Berkshire May Have Left $50 Billion on Table. Apple Stock Hit a Record. -- Barrons.com

20.10.2025 г., 21:49 ч. UTC

Придобивния, сливания и поглъщания

Kering Sells Beauty Business to L'Oréal. Everyone but This Company Wins. -- Barrons.com

20.10.2025 г., 20:56 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Moved the Most Today: Apple, Amazon, TSMC, Cleveland-Cliffs, Super Micro, Cooper Cos., Tesla, Netflix, and More -- Barrons.com

20.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

20.10.2025 г., 20:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

20.10.2025 г., 20:38 ч. UTC

Печалби

Steel Dynamics: Encouraging Demand Drivers of Manufacturing Onshoring, Infrastructure Program Funding, Lower Interest Rates, Increasing Regionalization of Supply Chains in U.S. >STLD

20.10.2025 г., 20:38 ч. UTC

Печалби

Steel Dynamics: Expect to Benefit From Stronger Demand Across Platforms, Including Aluminum Flat Rolled Products, as We Move Into 2026 >STLD

20.10.2025 г., 20:38 ч. UTC

Печалби

Steel Dynamics: Some Order Hesitancy From Flat Rolled Steel Customers Due to Domestic Trade Actions >STLD

20.10.2025 г., 20:36 ч. UTC

Печалби

Steel Dynamics: Continue to Observe Some Customer Inventory Overhang of Value-Added Flat Rolled Products That Were Imported Earlier This Yr >STLD

20.10.2025 г., 20:36 ч. UTC

Печалби

Steel Dynamics: View U.S. Intl Trade Commission's Final Determinations on Coated Flat Rolled Steel as a Significant Positive Development >STLD

20.10.2025 г., 20:36 ч. UTC

Печалби

Steel Dynamics: Discussions With Customers Reinforce the Increasing Importance of Low-Carbon, U.S.-Made Steel and Aluminum, Positioning Our Businesses for a Long-Term Competitive Advantage >STLD

20.10.2025 г., 20:36 ч. UTC

Печалби

Steel Dynamics: Improving Market Conditions, Including Increased Trade Stability and Favorable Interest Rate Environment, Will Contribute to Strong Domestic Demand for Steel and Aluminum >STLD

20.10.2025 г., 20:16 ч. UTC

Пазарно говорене

Canada Labor-Market Indicators Lean Dovish -- Market Talk

20.10.2025 г., 20:05 ч. UTC

Печалби

GE Aerospace Earnings Are on Tap. After the Turnaround, Investors Wonder What's Next. -- Barrons.com

20.10.2025 г., 19:39 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Industrials Post Positive Earnings. 3 Stocks Whose Charts Say 'Buy.' -- Barrons.com

20.10.2025 г., 19:34 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Jump on Colder Weather Outlook -- Market Talk

20.10.2025 г., 19:32 ч. UTC

Пазарно говорене

Oil Futures Extend Losses on Oversupply Concerns -- Market Talk

20.10.2025 г., 19:00 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Apple, Amazon, TSMC, Cleveland-Cliffs, Super Micro, Cooper Cos., Tesla, Netflix, and More -- Barrons.com

20.10.2025 г., 18:29 ч. UTC

Пазарно говорене

Apple Sitting on Best Long-Term Product Roadmap in Years -- Market Talk

20.10.2025 г., 18:11 ч. UTC

Пазарно говорене

Economic Vital Signs Missing in Bank of Canada Survey -- Market Talk

20.10.2025 г., 18:04 ч. UTC

Пазарно говорене

Uncertainty Remains Top Concern Among Canada Firms -- Market Talk

20.10.2025 г., 17:03 ч. UTC

Пазарно говорене

Weak Demand Signals Narrower Profit Margins For Canada Firms -- Market Talk

20.10.2025 г., 17:01 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

20.10.2025 г., 17:01 ч. UTC

Пазарно говорене

Bank of Canada Surveys Present Shaky Economic Outlook -- Market Talk

20.10.2025 г., 16:43 ч. UTC

Пазарно говорене

Canada Public-Sector Workers Fret Most On Labor-Market Weakness -- Market Talk

20.10.2025 г., 16:25 ч. UTC

Пазарно говорене

U.S. Natural Gas Extends Rebound on Weather Outlook -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Geron Corp Прогноза

Ценова цел

By TipRanks

175.59% нагоре

12-месечна прогноза

Среден 3.5 USD 175.59%

Висок 5 USD

Нисък 1.5 USD

Според 6 анализатори от Wall Street, предложили 12-месечна ценова цел за Geron Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

6 ratings

Купи

Задържане

Продай

Според 6 анализатори, дали борсови рейтинги на Geron Corp през последните 3 месеца.

Настроение

By Acuity

153 / 371 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.